Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10035966HBVENSG00000085563.15protein_codingABCB1YesNo5243A4D1D2
P08183
TVIS30067436HIVENSG00000085563.15protein_codingABCB1YesNo5243A4D1D2
P08183
TVIS20061554HPVENSG00000085563.15protein_codingABCB1YesNo5243A4D1D2
P08183
TVIS20061565HPVENSG00000085563.15protein_codingABCB1YesNo5243A4D1D2
P08183
TVIS20061861HPVENSG00000085563.15protein_codingABCB1YesNo5243A4D1D2
P08183
TVIS44008599HTLV-1ENSG00000085563.15protein_codingABCB1YesNo5243A4D1D2
P08183
TVIS44039492HTLV-1ENSG00000085563.15protein_codingABCB1YesNo5243A4D1D2
P08183
TCGA Plot Options
Drug Information
GeneABCB1
DrugBank IDDB04905
Drug NameTesmilifene
Target IDBE0001032
UniProt IDP08183
Regulation Typeinducer
PubMed IDs16413681; 10755318
CitationsVincent M: Tesmilifene may enhance breast cancer chemotherapy by killing a clone of aggressive, multi-drug resistant cells through its action on the p-glycoprotein pump. Med Hypotheses. 2006;66(4):715-31. Epub 2006 Jan 18.@@Brandes LJ, Queen GM, LaBella FS: N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine (DPPE) a chemopotentiating and cytoprotective agent in clinical trials: interaction with histamine at cytochrome P450 3A4 and other isozymes that metabolize antineoplastic drugs. Cancer Chemother Pharmacol. 2000;45(4):298-304.
GroupsInvestigational
Direct ClassificationDiphenylmethanes
SMILESCCN(CC)CCOC1=CC=C(CC2=CC=CC=C2)C=C1
Pathways
PharmGKB
ChEMBLCHEMBL26424